secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001193125-22-022381
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen announces retirement of directors Nancy Leaming and Brian Posner effective at 2022 annual meeting
--------------------------------------------------------------------------------

- Nancy Leaming and Brian Posner will retire from Biogen Board effective at the 2022 annual meeting of stockholders.
- Both directors have served since 2008; Leaming on Audit Committee, Posner as Chair of Compensation Management and Development Committee.
- Retirements are not related to any disagreement with the Board or the Company.
- No replacements have been announced yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312522022381/0001193125-22-022381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312522022381/d295583d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-022381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer